AI assistant
Sending…
SYSCO CORP — Director's Dealing 2019
Nov 20, 2019
30076_dirs_2019-11-20_3d582497-9d36-4598-9e6c-5f6172650e42.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYSCO CORP (SYY)
CIK: 0000096021
Period of Report: 2019-11-18
Reporting Person: Bertrand Greg D (EVP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-18 | Common Stock | M | 2994 | $33.40 | Acquired | 32872.97 | Direct |
| 2019-11-18 | Common Stock | S | 1225 | $81.61 | Disposed | 31647.97 | Direct |
| 2019-11-18 | Common Stock | M | 2571 | $38.89 | Acquired | 34218.97 | Direct |
| 2019-11-18 | Common Stock | S | 1225 | $81.61 | Disposed | 32993.97 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-18 | Stock Options (Right to buy) | $33.40 | M | 2994 | Disposed | 2023-11-14 | Common Stock (2994) | Direct |
| 2019-11-18 | Stock Options (Right to buy) | $38.89 | M | 2571 | Disposed | 2024-11-18 | Common Stock (2571) | Direct |
Footnotes
F1: The reported transaction involved a "net exercise" of outstanding stock options in which the Company withheld these shares to cover payment of the exercise price and applicable taxes using the closing price of the Company's common stock of $81.61 on November 18, 2019.
F2: Options are fully exercisable.
F3: Options granted by the Compensation and Leadership Development Committee of the company's Board of Directors pursuant to the 2013 Long Term Incentive Plan, as amended.
More from SYSCO CORP
M&A Activity
2026
Jun 2
Report Publication Announcement
2026
May 18
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 28
Earnings Release
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Mar 30